50268-788-15 : NDC 2026 Code

50268-788-15 : Valacyclovir Hydrochloride ( Valacyclovir Hydrochloride )

Additionally :

You can get information about “50268-788-15” NDC code in 50268-788-15 in HTML format

HTML | 50268-788-15 in TXT (Plain Text) format

TXT | 50268-788-15 in PDF (Portable Document Format)

PDF | 50268-788-15 in XML format

XML formats.

NDC Code : 50268-788-15 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "50268-788-15",
    "PackageDescription": "50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-788-15)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-788-11) ",
    "NDC11Code": "50268-0788-15",
    "ProductNDC": "50268-788",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Valacyclovir Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Valacyclovir Hydrochloride",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20140922",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA090682",
    "LabelerName": "AvPAK",
    "SubstanceName": "VALACYCLOVIR HYDROCHLORIDE",
    "StrengthNumber": "500",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-10-17",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20140922",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}